tiprankstipranks
Bastide le Confort Medical SA (GB:0IP1)
LSE:0IP1
UK Market
0IP1
Bastide le Confort Medical
RESEARCH TOOLSreports

Bastide le Confort Medical (0IP1) Ratios

0 Followers

Bastide le Confort Medical Ratios

GB:0IP1's free cash flow for Q2 2026 was €0.11. For the 2026 fiscal year, GB:0IP1's free cash flow was decreased by € and operating cash flow was €0.09. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Sep 24Jun 23Sep 22
Liquidity Ratios
Current Ratio
 1.16 1.38 0.97 0.87 1.07
Quick Ratio
 0.92 1.18 0.69 0.60 0.72
Cash Ratio
 0.15 0.13 0.11 0.16 0.13
Solvency Ratio
 0.18 0.10 0.11 0.12 0.13
Operating Cash Flow Ratio
 0.47 0.51 0.31 0.40 0.27
Short-Term Operating Cash Flow Coverage
 3.67 9.12 1.38 1.19 1.19
Net Current Asset Value
€ -283.96M€ -313.14M€ -357.42M€ -372.58M€ -359.25M
Leverage Ratios
Debt-to-Assets Ratio
 0.56 0.62 0.63 0.65 0.66
Debt-to-Equity Ratio
 3.15 5.70 5.12 4.88 4.96
Debt-to-Capital Ratio
 0.76 0.85 0.84 0.83 0.83
Long-Term Debt-to-Capital Ratio
 0.72 0.83 0.78 0.76 0.78
Financial Leverage Ratio
 5.65 9.16 8.11 7.50 7.48
Debt Service Coverage Ratio
 1.92 2.27 1.33 1.00 1.61
Interest Coverage Ratio
 1.53 1.27 1.42 2.21 2.55
Debt to Market Cap
 1.65 1.52 2.37 1.55 1.30
Interest Debt Per Share
 47.81 59.18 58.44 55.93 58.79
Net Debt to EBITDA
 3.02 3.78 3.59 3.98 4.42
Profitability Margins
Gross Profit Margin
10.31%67.80%66.91%65.69%65.51%
EBIT Margin
8.67%8.43%8.28%7.75%7.21%
EBITDA Margin
20.75%20.77%20.24%19.32%19.18%
Operating Profit Margin
8.98%7.97%7.35%7.22%6.95%
Pretax Profit Margin
2.43%2.15%3.12%4.48%4.49%
Net Profit Margin
6.19%0.11%-0.17%2.37%2.92%
Continuous Operations Profit Margin
1.62%0.82%1.79%3.31%3.22%
Net Income Per EBT
254.45%5.01%-5.45%52.92%65.10%
EBT Per EBIT
27.08%26.91%42.40%62.10%64.57%
Return on Assets (ROA)
5.07%0.08%-0.14%1.83%2.16%
Return on Equity (ROE)
33.68%0.73%-1.13%13.74%16.18%
Return on Capital Employed (ROCE)
10.36%8.50%9.03%8.48%7.11%
Return on Invested Capital (ROIC)
6.58%3.07%4.50%5.16%4.55%
Return on Tangible Assets
7.59%0.11%-0.21%6.10%7.24%
Earnings Yield
16.66%0.23%-0.63%5.31%5.27%
Efficiency Ratios
Receivables Turnover
 3.78 4.97 4.94 5.29 4.88
Payables Turnover
 4.98 2.13 2.28 2.39 2.53
Inventory Turnover
 10.78 3.96 2.97 2.89 2.63
Fixed Asset Turnover
 2.57 2.68 2.54 2.42 2.25
Asset Turnover
 0.82 0.74 0.82 0.77 0.74
Working Capital Turnover Ratio
 9.29 14.21 -29.55 -60.00 33.65
Cash Conversion Cycle
 57.01 -5.64 36.50 42.51 69.51
Days of Sales Outstanding
 96.46 73.51 73.88 69.06 74.74
Days of Inventory Outstanding
 33.86 92.20 122.97 126.44 138.95
Days of Payables Outstanding
 73.31 171.35 160.35 152.99 144.18
Operating Cycle
 130.32 165.71 196.86 195.50 213.69
Cash Flow Ratios
Operating Cash Flow Per Share
 10.72 13.63 8.85 11.37 6.36
Free Cash Flow Per Share
 4.06 5.59 1.43 4.62 -0.89
CapEx Per Share
 6.66 8.04 7.43 6.76 7.25
Free Cash Flow to Operating Cash Flow
 0.38 0.41 0.16 0.41 -0.14
Dividend Paid and CapEx Coverage Ratio
 1.59 1.68 1.16 1.66 0.84
Capital Expenditure Coverage Ratio
 1.61 1.69 1.19 1.68 0.88
Operating Cash Flow Coverage Ratio
 0.24 0.25 0.16 0.21 0.11
Operating Cash Flow to Sales Ratio
 0.17 0.21 0.12 0.18 0.10
Free Cash Flow Yield
17.06%17.86%7.45%16.14%-2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 6.00 442.74 -158.66 18.84 18.96
Price-to-Sales (P/S) Ratio
 0.37 0.48 0.27 0.45 0.55
Price-to-Book (P/B) Ratio
 1.72 3.24 1.79 2.59 3.07
Price-to-Free Cash Flow (P/FCF) Ratio
 5.86 5.60 13.42 6.20 -39.83
Price-to-Operating Cash Flow Ratio
 2.24 2.30 2.16 2.51 5.55
Price-to-Earnings Growth (PEG) Ratio
 <0.01 -2.78 1.48 -1.46 11.57
Price-to-Fair Value
 1.72 3.24 1.79 2.59 3.07
Enterprise Value Multiple
 4.80 6.07 4.92 6.29 7.31
Enterprise Value
 474.11M 619.43M 527.83M 617.71M 656.50M
EV to EBITDA
 4.80 6.07 4.92 6.29 7.31
EV to Sales
 1.00 1.26 1.00 1.22 1.40
EV to Free Cash Flow
 15.84 14.84 49.59 16.86 -100.80
EV to Operating Cash Flow
 6.00 6.08 7.99 6.84 14.04
Tangible Book Value Per Share
 -12.24 -16.16 -18.33 -46.79 -48.59
Shareholders’ Equity Per Share
 13.95 9.66 10.69 11.04 11.51
Tax and Other Ratios
Effective Tax Rate
 0.33 0.62 0.43 0.26 0.28
Revenue Per Share
 64.63 65.77 71.01 64.00 63.73
Net Income Per Share
 4.00 0.07 -0.12 1.52 1.86
Tax Burden
 2.54 0.05 -0.05 0.53 0.65
Interest Burden
 0.28 0.25 0.38 0.58 0.62
Research & Development to Revenue
 0.00 0.00 0.00 <0.01 0.00
SG&A to Revenue
 <0.01 0.00 0.00 0.00 0.16
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 <0.01 <0.01
Income Quality
 11.04 65.27 8.95 5.62 3.24
Currency in EUR